Virtu Financial LLC Purchases New Shares in Helius Medical Technologies, Inc. (NASDAQ:HSDT)

Virtu Financial LLC acquired a new position in shares of Helius Medical Technologies, Inc. (NASDAQ:HSDT) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 46,510 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned about 1.25% of Helius Medical Technologies as of its most recent SEC filing.

Helius Medical Technologies Trading Up 9.5 %

Shares of NASDAQ HSDT opened at $0.44 on Wednesday. Helius Medical Technologies, Inc. has a 1-year low of $0.37 and a 1-year high of $7.19. The company has a 50-day moving average of $0.52 and a two-hundred day moving average of $0.58. The company has a market cap of $1.64 million, a PE ratio of -0.07 and a beta of 1.62.

Helius Medical Technologies (NASDAQ:HSDT) last posted its quarterly earnings data on Tuesday, March 25th. The company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.94) by ($0.09). The company had revenue of $0.15 million during the quarter, compared to the consensus estimate of $0.10 million. Helius Medical Technologies had a negative return on equity of 244.82% and a negative net margin of 1,764.74%.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.